Japan MPS Initiative 2026

Join InSphero at the Japan MPS Initiative

The Japan MPS Initiative 2026 brings together leading experts in microphysiological systems and organ-on-chip technologies to discuss the latest scientific advances shaping drug discovery, toxicology, and regulatory science.

The meeting will highlight efforts to establish standards, share validation data, and harmonize with international groups advancing NAMs. Join us in Tokyo on  Wednesday, January 21st! 

Meet our Team at the Japan MPS Initiative

Jan Lichtenberg

Jan Lichtenberg, PhD

CEO and Co-Founder

Scientific Talk at the Japan MPS Initiative

Integrating 3D Liver Models for Translation to Man into IND Submissions: Cross-Species Mechanistic Insights into Cholestatic Toxicity

Date: Wednesday, January 21st at 16:00 

Location: Tower Hall Funabori   

Jan Lichtenberg

Jan Lichtenberg, PhD

CEO and Co-Founder

Japan MPS Initiative 2026

Toward Patient-Relevant DILI Testing: Integrating Intrinsic Liver Vulnerability with Systemic Metabolic Cues
Studying Fibrosis using 3D InSight Human MASH Microtissues Leveraging ZEISS Lattice Lightsheet 7 for 3D High-Content Analysis
Scalable Whole-Plate Calcium Imaging of Human iPSC-Derived Neural Spheroids for Drug Screening and Neurotoxicity Assessment
Non-Destructive Multiplexed Imaging of 3D Liver Microtissues for Multi-Modal DILI Assessment
Gri3D® Hydrogel Microcavity Plates
Gri3D® One Platform – Endless Possibilities
Selection Guide Akura™/Gri3D®
Multiparameter-based assays in 3D human liver microtissues: Towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource